Skip to main content
Premium Trial:

Request an Annual Quote

IP Roundup: PLC Diagnostics, Affymetrix, One Lambda, Massachusetts Institute of Technology, Illumina


Title: System and method for nucleic acids sequencing by phased synthesis.
Patent Number: 8,747,751
Filed: June 10, 2009
Lead Inventor: Reuven Duer, PLC Diagnostics

Title: Multiple step printing methods for microbarcodes.
Patent Number: 8,748,079
Filed: Jan. 11, 2013
Lead Inventor: Randall True, Affymetrix

Title: Method of screening for binding interaction using sets of microparticles and unique probes.
Patent Number: 8,748,090
Filed: May 2, 2008
Lead Inventor: Jar-How Lee, One Lambda

Title: Multiplexed olfactory receptor-based microsurface plasmon polariton detector.
Patent Number: 8,748,111
Filed: Jan. 28, 2011
Lead Inventor: Andreas Mirshin, Massachusetts Institute of Technology

Title: Assay instrument for detecting optical signals from samples.
Patent Number: 8,748,789
Filed: May 30, 2013
Lead Inventor: Alexander Triener, Illumina

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.